Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Portieria hornemannii strain:PH1-13P

ABSTRACT: Portieria hornemannii strain:PH1-13P Raw sequence reads

PROVIDER: PRJNA1008268 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

The chromatin determinants and Ph1 gene effect at wheat sites with contrasting recombination frequency

Project description:This study aims to investigate a wheat recombination hotspot (H1) in comparison with a “regular” recombination site (Rec7) on the sequence and epigenetic level in conditions with functional and non-functional Ph1 locus.

2022-12-14 | GSE220598 | GEO

Staphylococcus epidermidis strain:PH1-28

Project description:Staphylococcus epidermidis PH1-28 genome, complete sequence

| PRJNA662445 | ENA

Aequitasia blattaphilus strain:PH1-16

Project description:Aequitasia blattaphilus strain:PH1-16 Genome sequencing

| PRJNA834453 | ENA

Morus alba Raw protein sequence reads

Project description:Morus alba L. Raw protein sequence reads and sequence

2024-02-08 | PXD049451 |

Staphylococcus aureus strain:ph1

Project description:Staphylococcus aureus ph1 Genome sequencing and assembly

| PRJNA486724 | ENA

Peptoniphilus obesi ph1

Project description:Peptoniphilus obesi ph1 Genome sequencing and assembly

| PRJEA82275 | ENA

Lachnospiraceae bacterium PH1-22

Project description:Lachnospiraceae bacterium PH1-22 Genome sequencing

| PRJNA834217 | ENA

Maximizing HLC production in bioreactors: unveiling the role of oxygen control for enhanced yield and PH1 disease modelling

Project description:Hepatocytes-like cells (HLC) derived from human induced pluripotent stem cells show great promise for cell-based liver therapies and disease modelling. However, their application is currently hindered by the low production yields of existing protocols. We aim to develop a bioprocess able to generate high numbers of HLC. We used stirred-tank bioreactors with a rational control of dissolved oxygen concentration (DO) for the optimization of HLC production as 3D aggregates. We evaluated the impact of controlling DO at physiological levels (4%O2) during hepatic progenitors’ stage on cell proliferation and differentiation efficiency. Whole transcriptome analysis and biochemical assays were performed to provide a detailed characterization of HLC quality attributes. When DO was controlled at 4%O2 during the hepatic progenitors’ stage, cells presented an upregulation of genes associated with hypoxia-inducible factor pathway and a downregulation of oxidative stress genes. This condition promoted higher HLC production (maximum cell concentration: 2×106 cell/mL) and improved differentiation efficiencies (80% Albumin-positive cells) when compared to the bioreactor operated under atmospheric oxygen levels (21%O2, 0.6×106 cell/mL, 43% Albumin positive cells). These HLC exhibited functional characteristics of hepatocytes: capacity to metabolize drugs, ability to synthesize hepatic metabolites, and inducible cytochrome P450 activity. Bioprocess robustness was confirmed with HLC derived from different donors, including a primary hyperoxaluria type 1 (PH1) patient. The generated PH1.HLC showed metabolic features of PH1 disease with higher secretion of oxalate compared with HLC generated from healthy individuals. This work reports a reproducible bioprocess, that shows the importance of controlling DO at physiological levels to increase HLC production, and the HLC capability to display PH1 disease features.

2024-10-23 | GSE267210 | GEO

Staphylococcus epidermidis strain:R10C | isolate:PH1-18

Project description:Staphylococcus epidermidis strain:R10C | isolate:PH1-18 Genome sequencing and assembly

| PRJNA721836 | ENA

Staphylococcus epidermidis strain:11H | isolate:PH1-4

Project description:Staphylococcus epidermidis strain:11H | isolate:PH1-4 Genome sequencing and assembly

| PRJNA721837 | ENA